UF study finds 1 in 16 women take harmful drugs during pregnancy – UF Health News

The University of Florida Academic Health Center – the most comprehensive academic health center in the Southeast – is dedicated to high-quality programs of education, research, patient care and public service.
The UF College of Dentistry is the only public-funded dental school in Florida and is recognized as one of the top U.S. dental schools for the quality of its educational programs, oral health research enterprise and commitment to patient care and service.
The College of Medicine, the largest of six colleges at the University of Florida Academic Health Center, opened in 1956 with a mission to increase Florida’s supply of highly qualified physicians, provide advanced health-care services to Florida residents and foster discovery in health research.
Founded in 1956, the University of Florida College of Nursing is the premier educational institution for nursing in the state of Florida and is ranked in the top 10 percent of all nursing graduate programs nationwide. The UF College of Nursing continually attracts and retains the highest caliber of nursing students and faculty with a passion for science and caring.
Established in 1923, the College of Pharmacy is the oldest college in the UF Academic Health Center. Ranked among the top schools of pharmacy nationally, the college supports research, service and educational programs enhanced with online technologies.
The College of Public Health & Health Professions (PHHP) is dedicated to providing excellent educational programs that prepare graduates to address the multifaceted health needs of populations, communities and individuals.
The UF College of Veterinary Medicine is Florida’s only veterinary college and provides many unique educational programs for students and services aimed at helping pets, wildlife and endangered species. We offer a a four-year Doctor of Veterinary Medicine programs as well as M.S. and Ph.D. degrees in Veterinary Medical Sciences.
Co-located with the Shands Jacksonville Hospital, the Jacksonville Health Science Center excels in education, research and patient care that expresses our abiding values of compassion, excellence, professionalism and innovation. Our state-of-the-art medical center serves an urban population of 1 million from north Florida to south Georgia.
The UFCOM-J offers accredited graduate medical education residency and fellowship programs, in addition to non-standard fellowship programs. Clinical rotations in all the major disciplines are provided for UFCOM undergraduate medical students and elective rotations to students from other accredited schools.
The UFHSC-J is a clinical teaching site for the Gainesville-based College of Nursing. Students rotate through the various clinical settings on the campus, and primary care centers and specialty care centers located throughout Jacksonville.
The UF College of Pharmacy-Jacksonville offers a four-year Doctor of Pharmacy (Pharm.D.) Program completed entirely in Jacksonville. Also offered on campus is an American Society of Health-System Pharmacists-accredited pharmacy residency program at Shands Jacksonville.
University of Florida Health knows how important ongoing medical learning is to health care providers and the community. That is why we provide online Continuing Medical Education (CME) courses for you to complete for CME credits. These courses share the latest in medical knowledge, teach new patient-relationship skills and help providers deal with relevant current issues.
Learn about UF clinical research studies that are seeking volunteers.
The best way to prevent the spread of COVID-19 is to get vaccinated. You can get a vaccine in many places in your community. Find a walk-up location or schedule an appointment today.Read more
Almut Winterstein, Ph.D., R.Ph.In a review of more than 3 million pregnancies, University of Florida researchers found 1 in 16 women were exposed to harmful teratogenic drugs — medications that can cause pregnancy loss, birth defects and other health problems for the unborn child.
The study published in the American Journal of Obstetrics and Gynecology highlights the need for women and their providers to carefully examine medications taken during pregnancy.
“If you are pregnant, planning to become pregnant, or sexually active you must understand the risks involved with taking teratogenic drugs,” said Almut Winterstein, Ph.D., R.Ph., an author of the study and distinguished professor and chair of the department of pharmaceutical outcomes and policy in the UF College of Pharmacy, part of UF Health.
“Talk with your provider about your medications and review drug labels to ensure the medications you are taking are not putting your unborn child at risk,” added Winterstein, who also directs the UF Center for Drug Evaluation and Safety.
A teratogen is a substance that interferes with the normal development of a fetus. Hundreds of such drugs have been identified, including medications to treat seizures, migraines, obesity, acne, hypertension, bipolar disease and cancer.
UF researchers investigated more than 200 teratogenic drugs and evaluated their exposure among 3.4 million pregnancies identified in a national private insurance database from 2006 to 2017. Prenatal exposure was defined by the mother taking at least one teratogenic drug during pregnancy.
Using teratology drug databases, the medications were separated into two classes based upon their known teratogenic effect. About 140 drugs were known to have definite teratogenic effects, and another 65 were identified as having potential teratogenic effects. The proportion of pregnancies with exposure to definite teratogens decreased slightly over the 12-year study period from 1.9% to 1.2%, while exposures for potential teratogens increased from 3.4% to 5.3%.
“While declining exposure rates among teratogenic drugs with definite risk are encouraging, the rising prenatal exposure to drugs with potential risk calls for more assessment,” Winterstein said. “To have 1 in 16 women and their unborn baby exposed to a teratogenic medication is simply too high, and we must identify strategies to improve pregnancy outcomes.”
The study also examined age and risk for prenatal exposure to teratogenic drugs and found teenagers and women in their 40s had the greatest risk. Winterstein said both of these groups are known to have more unintended pregnancies and the drug exposure may have been accidental, which points to the need for more information about effective birth control and family planning when using teratogenic drugs.
UF researchers were particularly interested in prenatal exposure during more recent years, following the enactment of the FDA Amendment Act of 2007. That legislation allowed the U.S. Food and Drug Administration to require drug manufacturers to implement a risk evaluation and mitigation strategy for certain medications with serious safety concerns. Those mitigation strategies are designed to reinforce safe medication-use behaviors, such as a pregnancy test before a teratogenic drug is started, and only a few medications require this extra safety precaution.
The 12 drugs with mitigation protocols in the study were found to be used infrequently and contributed to only a small portion of prenatal exposures. The study’s authors concluded more research and regulatory action are needed to optimize the use of medications during pregnancy.
“There is much to do to address the evidence available regarding the risk-benefit of many drugs during pregnancy, and the availability of adequate risk-mitigation programs that ensure pregnancies are not unnecessarily exposed to teratogenic drugs,” Winterstein said. “In the meantime, women and their providers must rely on the written information that is provided about the teratogenic risk for drugs during pregnancy.”
The study “Prenatal Exposure to Teratogenic Medications in the Era of Risk Evaluation and Mitigation Strategies (REMS),” was published in the American Journal of Obstetrics and Gynecology. Amir Sarayani, Pharm.D., M.P.H., a doctoral candidate in the UF College of Pharmacy under Winterstein’s mentorship, served as the lead author of the paper. Additional contributions were made by Sonja Rasmussen, M.D., M.S., a professor in the departments of pediatrics and epidemiology in the UF College of Medicine.
Media contact: Ken Garcia at kdgarcia@ufl.edu or 352-273-9799.
Director of Communications, College of Pharmacy

Matt Splett is director of communications for the College of Pharmacy. He leads efforts to enhance the college’s brand image through traditional and new media initiatives and serves as executive…Read More
Together we discover. Together we teach.
Together we care for our patients and our communities.
Together we create unstoppable momentum.

The Foundation for The Gator Nation
© 2022 University of Florida Health


Add a Comment

Your email address will not be published. Required fields are marked *